Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase NA 4Phase 1/2 4Phase 2 2Phase 3 1Phase 2/3 1

Status

Completed 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 1Classical hematology 1

Conditions

Breast Neoplasms 3863Neoplasms 2988Prostatic Neoplasms 1754Colorectal Neoplasms 1430Lung Neoplasms 1331Motor Activity 805Head and Neck Neoplasms 686Pancreatic Neoplasms 663Colonic Neoplasms 655Uterine Cervical Neoplasms 653Carcinoma, Non-Small-Cell Lung 631Carcinoma, Hepatocellular 631Rectal Neoplasms 571Stomach Neoplasms 547Brain Neoplasms 484Ovarian Neoplasms 441Anxiety Disorders 420Pain 419Neoplasm Metastasis 385Esophageal Neoplasms 384Polycystic Ovary Syndrome 374Precursor Cell Lymphoblastic Leukemia-Lymphoma 354Urinary Bladder Neoplasms 351Fatigue 340Melanoma 323Multiple Myeloma 322Lymphoma 306Depression 306Endometrial Neoplasms 290Liver Neoplasms 279

Interventions

Dipyrone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Interventional × Hemostatic Disorders × Clear all
NCT07384013 2026-02-03

Study Protocol: Impact of Metamizole (OptalginĀ®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs

Rambam Health Care Campus

Phase NA Recruiting
30 enrolled

Agnosia, Hemostatic Disorders

NCT03826043 2025-09-30

THEO

Centre Antoine Lacassagne

Phase NA Completed
700 enrolled

Neoplasms, Thrombosis, Hemostatic Disorders

NCT05634005 2025-03-06

Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence

University of Utah

Phase NA Completed
1,543 enrolled
Classical hematologyLymphoid

Afibrinogenemia, Anemia, Lymphoma, Follicular, Thrombocytopenia, Hemostatic Disorders

NCT03993977 2020-12-16

ROTEM-SUR

Tampere University Hospital

Phase NA Withdrawn

Neoplasms, Blood Loss, Surgical, Hemostatic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚔